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A 33-year-old woman presented with bilateral 
breast pain 5 years following submuscular augmenta-
tion mammoplasty. There was no history of trauma. 
The implants were textured silicone Poly Implant 
Prothese (PIP) 390 cm3 implants. Examination re-
vealed bilateral tender D-cup breasts and tender 
axillary lymph nodes. Magnetic resonance imaging 
(MRI) demonstrated bilateral extracapsular implant 
rupture with bilateral internal mammary and axil-
lary lymphadenopathy (Fig. 1). The patient elected 
against having the implants replaced. She underwent 
explantation and total capsulectomy. A selective ex-
cision of palpably enlarged bilateral level 1 axillary 
lymph nodes was also performed at her request. His-
tology demonstrated a fibrous pseudocapsule with 
silicone material throughout and silicone lymphade-
nopathy with no evidence of malignancy. The lymph 
nodes showed partial effacement of the architecture 
by nonnecrotizing granulomatous inflammation, 
with a prominent foreign body giant cell reaction. 
Clear vacuoles were seen within the cytoplasm, con-
sistent with the presence of silicone (Fig. 2).
Four months following surgery, she presented 
with a tender left supraclavicular mass. She also 
complained of intermittent glove-like paresthesiae 
of her left hand; however, neurological examination 
was normal. MRI demonstrated bilateral lymphade-
nopathy of the axillae and supraclavicular regions 
and a single enlarged mediastinal node. Following 
discussion with a hematologist with a specialist inter-
est in lymphoproliferative disease, she underwent 
excision biopsy of 5 left-sided supraclavicular nodes 
to exclude lymphomatous malignancy. Histology re-
vealed silicone lymphadenopathy with no evidence 
of malignancy. Immunophenotyping of the nodes 
revealed a polyclonal B-cell population, and periph-
eral bloods showed an increased concentration of 
natural killer cells. A bone marrow biopsy was per-
formed to further investigate the natural killer cell 
Disclosure: The authors have no financial interest 
to declare in relation to the content of this article. The 
Article Processing Charge was paid for by the Depart-
ment of Plastic and Reconstructive Surgery, Royal 
Adelaide Hospital.
Thoracic Outlet Syndrome Following Breast 
Implant Rupture
From the *Department of Plastic and Reconstructive Surgery, 
Royal Adelaide Hospital, North Terrace, Adelaide, South 
Australia; †Department of Haematology, Royal Adelaide 
Hospital, North Terrace, Adelaide, South Australia; and 
‡Anatomical Pathology, SA Pathology, Royal Adelaide 
Hospital, North Terrace, Adelaide, South Australia.
Received for publication January 16, 2015; accepted January 
30, 2015.
Copyright © 2015 The Authors. Published by Wolters 
Kluwer Health, Inc. on behalf of The American Society of 
Plastic Surgeons. All rights reserved. This is an open-access 
article distributed under the terms of the Creative Commons 
Attribution-NonCommercial-NoDerivatives 3.0 License, 
where it is permissible to download and share the work 
provided it is properly cited. The work cannot be changed in 
any way or used commercially.
DOI: 10.1097/GOX.0000000000000295
Raakhi Mistry, MBChB*
Yugesh Caplash, MBBS, 
FRACS*
Pratyush Giri, MBBS, FRACP, 
FRCPA†
Daniel Kearney, MBBS, 
FRCPA‡
Marcus Wagstaff, MBBS, PhD, 
FRACS*
Mistry et al.
Summary: We present a patient with bilateral breast implant rupture who 
developed severe locoregional silicone granulomatous lymphadenopathy. 
Poly Implant Prothese silicone implants had been used for bilateral breast 
augmentation 5 years prior. Extracapsular implant rupture and bilateral 
axillary lymphadenopathy indicated explantation, capsulectomy, and  selective 
lymph node excision. Histology demonstrated silicone lymphadenopathy with 
no evidence of malignancy. Over the subsequent 12 months, she  developed 
progressive locoregional lymphadenopathy involving bilateral cervical, 
 axillary, and internal mammary groups, resulting in bilateral thoracic outlet 
syndrome. We report the unusual presentation, progression, and the ultimate 
surgical management of this patient. (Plast Reconstr Surg Glob Open 2015;3:e331; 
doi: 10.1097/GOX.0000000000000295; Published online 18 March 2015.)
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population and demonstrated no evidence of lym-
phoproliferative disease. A trial of prednisolone was 
commenced to suppress the granulomatous reac-
tion. Clinically the lymphadenopathy and paresthe-
sia subsided within 2 weeks of commencing steroids. 
After 4 weeks, however the steroids were ceased due 
to extensive folliculitis.
She re-presented 4 months later with a tender left 
supraclavicular mass. MRI demonstrated bilateral 
axillary, internal mammary, supraclavicular, and up-
per paratracheal lymphadenopathy. This extended 
along the course of the brachial plexuses with mild 
mass effect. In order to exclude lymphoproliferative 
change, she underwent excision biopsy of 3 left-sided 
supraclavicular nodes and 1 right-sided supraclavicu-
lar node. Histology revealed silicone lymphadenopa-
thy with no evidence of malignancy.
Three weeks following surgery, she presented 
with tender bilateral supraclavicular swelling, cold-
ness, and numbness in both arms and hands, which 
felt “dead” on waking but were relieved by shaking. 
Examination revealed altered sensation and reduced 
power in C4-T2 distribution and positive Adson’s 
and Roos’ provocative tests for thoracic outlet com-
pression. MRI images were unchanged. The major-
ity of the mass effect was exerted at the level of the 
brachial plexus divisions and cords (Fig. 3). Given 
the severity and progressive nature of her symptoms, 
along with the radiological findings and after discus-
sion with the hematologist, we recommended she 
undergo targeted excision of enlarged lymph nodes 
in the proximity of the brachial plexus. This was 
performed via supraclavicular to deltopectoral inci-
sions and axillary incisions (Fig. 4). On the right, the 
clavicle was split for access and later osteosynthesised 
(Fig. 5). Bilateral brachial plexuses were exposed at 
level V and enlarged nodes excised. In addition, a 
bulky level IV node was excised on the right, and 
bulky level III/IV nodes were excised on the left. 
Enlarged nodes from bilateral axillary level II and 
Fig. 1. axial MRI from first presentation demonstrating extra-
capsular implant rupture and axillary and internal mammary 
lymphadenopathy.
Fig. 2. Histology slide of lymph node demonstrating silicone 
lymphadenopathy, H&e ×100.
Fig. 3. Coronal MRI demonstrating mass effect on bilateral 
brachial plexuses.
Fig. 4. preoperative photograph of the proposed supracla-
vicular to deltopectoral incisions used to access the bilateral 
brachial plexuses. previous biopsy incisions were incorpo-
rated. the acromions are also marked.
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III were excised. Histology revealed silicone lymph-
adenopathy with no evidence of malignancy. Within 
a day of surgery, her hand sensation improved and 
provocative tests were negative. Over the following 3 
months, she regained normal sensation, power, and 
range of motion.
Six months following surgery, she presented 
with symptoms of thoracic outlet compression on 
the left side. Examination revealed tender swell-
ing in the left supraclavicular fossa, altered sensa-
tion and reduced power in C4-T2 distribution, and 
positive Adson’s and Roos’ test. MRI demonstrated 
asymmetrically enlarged left supraclavicular lymph 
nodes closely associated with the cords of the bra-
chial plexus. Following further multidisciplinary 
discussion, she underwent an en bloc level 5 lymph 
node clearance. A significant number of enlarged 
nodes were cleared under omohyoid, trapezius, and 
inferior to the clavicle. Histology revealed silicone 
lymphadenopathy with no evidence of malignancy. 
Four months following surgery, she regained normal 
sensation, power, and range of motion, with no evi-
dence of lymphoedema.
DISCUSSION
This is the first documented case of silicone 
lymphadenopathy resulting in thoracic outlet syn-
drome. The patient presented 4 times over the course 
of 12 months with lymphadenopathy. Given the dif-
ferential diagnosis of lymphoma, a hematologist was 
consulted. Analysis of peripheral blood, bone mar-
row biopsy, and lymph node biopsy was performed 
at each stage to exclude lymphoproliferative change. 
In this case, the silicone appeared to stimulate a 
chronic granulomatous reaction. Despite its initial 
reputation as a biologically inert substance, silicone 
has been associated with local and systemic granulo-
matous inflammatory reactions affecting breast tis-
sue and lymph nodes. When leakage occurs, silicone 
can be transported to regional lymph nodes by mac-
rophages in the reticuloendothelial system resulting 
in chronic foreign body granulomatous reactions. In 
the majority of cases, silicone migration is limited to 
the axillary lymph nodes. However, spread to other 
groups is possible.1–4
A recent worldwide review of patients with implant-
associated anaplastic large cell lymphoma (ALCL) 
showed that 17% of patients presented with axillary 
lymphadenopathy.5 As such, it was important to ex-
clude implant-associated ALCL. In general, implant-
associated ALCL has an indolent clinical course with 
the mean interval between implant insertion and lym-
phoma diagnosis being 9 years (range, 1–32 years).5 
To date, no cases of ALCL have been diagnosed in pa-
tients with PIP implants. The risk of malignant trans-
formation is not known for PIP implants or silicone 
granulomatous disease, and therefore, we plan to 
monitor this patient’s progress long term from both 
hematological and surgical point of view.
The breast implants in this case were manufac-
tured by PIP. This is noteworthy to mention as the sale 
of these implants was suspended in March 2010 after 
the French Health Products Safety Agency found that 
the silicone gel used by PIP was not medical grade 
and therefore did not comply with Conformité Euro-
péenne marking.6 Physicochemical analysis has dem-
onstrated that PIP implants have increased levels of 
low-molecular-weight siloxanes compared with med-
ical-grade breast implants. However, cytotoxic and 
genotoxic tests have shown no acute toxic effect. Clin-
ically, these implants have been shown to have a high-
er rupture rate than medical-grade implants.7,8 Cases 
of PIP implant rupture associated silicone lymphade-
nopathy have been reported in the literature. In all of 
these cases, the silicone has migrated to cervical and/
or axillary lymph nodes.1,4,8–10
There is no current consensus on the manage-
ment of silicone granulomatous disease.2,4 Options 
include conservative, immunosuppression, or surgical 
excision. Recurrence has been reported following 
surgical excision.2 There is a paucity of literature on 
immunosuppressive therapy for silicone granulo-
matous disease. In this case, the patient did not tol-
erate corticosteroid therapy, and therefore, it was 
ceased. Alternative immunosuppressants were not 
used due to their cytotoxic side effects. She then 
developed further lymphadenopathy over a period 
of 12 months, with worsening neuropathic symptoms. 
Fig. 5. Intraoperative photograph of the root of the right neck 
taken from a cephalic viewpoint. the clavicle is divided, and 
the displacement effect of anterior and posterior enlarged 
lymph nodes on the brachial plexus can be seen.
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However, as the symptoms were becoming more 
severe, with MRI confirmation of mass effect, we 
proposed a more comprehensive excision of grossly 
enlarged lymph nodes for symptom relief. Given the 
necessary cutaneous scars for access and the poten-
tial risks of such an operation, these decisions were 
made after careful consideration and discussion with 
orthopedic, thoracic, and vascular surgeons, the he-
matologist, and the patient. Complete cervical and 
axillary lymph node clearance was not planned at this 
stage due to the risk of lymphoedema. Although ini-
tially effective in symptom relief, when she presented 
6 months later with left-sided thoracic outlet symp-
toms, the decision was made to formally clear the level 
5 lymph nodes encroaching on the brachial plexus. 
This has again resolved her symptoms, accepting that 
lymphoedema may still present as a long-term compli-
cation. We propose indications for surgical excision 
include biopsy to exclude malignancy and symptom-
atic relief where medical management has failed. 
Raakhi Mistry, MBChB
Department of Plastic and Reconstructive Surgery
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Patient provided written consent for the use of her images.
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